Express Scripts 2013 Annual Report Download - page 97

Download and view the complete annual report

Please find page 97 of the 2013 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

97 Express Scripts 2013 Annual Report
We can give no assurance that such judgments, fines and remedies, and future costs associated with any such matters would not
have a material adverse effect on our financial condition, our consolidated results of operations or our consolidated cash flows.
We previously disclosed an accrual of $30.0 million related to a client contractual dispute. The accrual was
reflected as an offset to revenue in the consolidated statement of operations for the year ended December 31, 2011. In 2012,
this dispute was resolved and the impact of the resolution was not material.
13. Segment information
We report segments on the basis of services offered and have determined we have two reportable segments: PBM
and Other Business Operations. During 2013, we determined our acute infusion therapies line of business which was acquired
in the Merger and previously included within our PBM segment was no longer core to our future operations and committed to a
plan to dispose of this business. During 2012, we determined that various portions of UBC, our European operations and EAV
acquired in the Merger that were previously included within our Other Business Operations segment were no longer core to our
future operations and committed to a plan to dispose of these businesses. In accordance with applicable accounting guidance,
the results of operations for these businesses are reported as discontinued operations for all periods presented in the
accompanying information. During the second quarter of 2012, we reorganized our international retail network pharmacy
administration business (which was substantially shut down as of December 31, 2012) from our PBM segment into our Other
Business Operations segment. During the third quarter of 2011, we reorganized our FreedomFP line of business from our Other
Business Operations segment into our PBM segment.